Journal of Clinical Oncology, ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol , No 18S ( Supplement), :
© 2008 American Society of Clinical Oncology

Return to article

wTCF n=50 wTX n=56 Age Median (range) 62 (36–83) 60 (33–79) PS0–1 (%) 98 97 Male sex (%) 84 75 Confirmed PR+CR (%) (95% CI) 49 (35–63) 26 (16- 39) Febrile neutropenia/neutropenic infection (%) 4 2 Gr 3/4 lethargy (%) 10 4 Gr 3/4 diarrhea (%) 10 7 Gr 3/4 stomatitis (%) 22 2 Gr 3 hand-foot syndrome (%) 4 2

Return to article